MedPath

Kadcyla

Brand Name: Kadcyla

Generic Name: Trastuzumab Emtansine

Active
Registration Number

BR-953

Dosage Form

Powder For Concentrate For Solution For I.V. Infusion

Issuance Date

May 6, 2024

Expiry Date

June 30, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg
Packaging15mL Type I Glass Vial sealed with a grey butyl rubber stopper with an aluminum seal and a white plastic flip-off cap (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Monoclonal Antibody
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Trastuzumab EmtansineActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform